Scott and Anne Marie welcome back Eric Pachman, a consultant and drug pricing analyst with 46Brooklyn. 46Brooklyn is committed to bringing transparency to your prescription transactions, and today Eric talks about spread: the gap between the amount the pharmacy receives for the drug vs. what the payer paid. It should be a simple transaction fee; but because of secretive contracts that bear no correlation to the actual price of the drug, middlemen are raking in profit at the expense of employers.
Eric Pachman is the founder and a consultant of drug pricing analytics at 46brooklyn LLC. Our country’s prescription supply chain is sick. At 46brooklyn, we believe the cure starts with a healthy dose of data and transparency. Our mission is to remedy our nation’s drug pricing illness by first spreading data-driven awareness of the system’s problems. We clean-up and join together the ample public data sources on drug pricing. We build visualizations to more efficiently ask questions and get answers from our data. We publish thought-provoking research. And we provide consulting services to those companies that share our mission of improving drug pricing transparency.
We all know that prescription drug prices are costing us a lot of money. One Ohio company is doing something about it. 46Brooklyn was created to obtain, analyze and release data on pharmaceutical pricing. Listen as these two men explain how they are using data to make drug pricing transparent.
Side Affects listeners were among the first to hear about new approaches to paying for health care, including the cost/quality relationship, pricing transparency and value-based contracting. Scott McGohan and Anne Marie Singleton look at how these new conversations are changing the mindset of employers.